Latest News for: cisplatin

Edit

Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS 401 for the Prevention of Cisplatin Induced Ototoxicity (Sensorion SA)

Public Technologies 07 Mar 2025
NCT05628233) evaluates the efficacy of SENS-401 in preventing CIO in adult patients with neoplastic disease, four weeks after completion of cisplatin-based chemotherapy ... after cisplatin administration.
  • 1
×